StockWatch
·

PCBL Ltd

BSE: 506590

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
1.7K
+3.2%+15.2%
Expenditure
1.6K
+6.0%+14.0%
Net Profit
80.01
-25.4%+34.2%
OPM %
11.86%
-2.56pp-0.29pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00478.83957.661.4K1.9KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

YoY Growth Masks the Real Story—Sequential Collapse and Aquapharm's Deferred Promise

carbon black · margin compression · Aquapharm miss

Result verdictFollow-upQ2 FY2706 Nov 20266 minMetals & Mining

Growth credible, but margin compression and Aquapharm miss signal execution risk

carbon black · pricing discipline · Aquapharm deferred

TranscriptDeep diveQ2 FY2706 Nov 20266 minMetals & Mining

PCBL Chemical: Cons. PAT +20% YoY to ₹74 Cr, but margins cool sharply from Q1 peak

carbon black · margin compression · inventory gain reversal

ResultsQ2 FY2702 Nov 20263 minMetals & Mining
Latest
Quarterly Result2 Nov, 1:22 pm

PCBL Chemical: Cons. PAT +20% YoY to ₹74 Cr, but margins cool sharply from Q1 peak

PCBL Chemical's consolidated PAT rose 20.2% YoY to ₹74.14 Cr (from ₹61.70 Cr) on revenue growth of 14.4% YoY to ₹2,474.45 Cr, with basic EPS at ₹1.88 versus ₹1.63 a year ago. Sequentially, though, PAT fell 52.1% from Q1 FY27's ₹154.93 Cr even as revenue was flat QoQ (₹2,473.37 Cr) — a pure margin story, not a demand one. Standalone PAT of ₹80.01 Cr came in ~8% above the consolidated figure, with the gap explained by the Chemical segment (Aquapharm and peers), which posted segment PBIT of just ₹5.24 Cr on ₹433.25 Cr of revenue this quarter. The margin compression sits almost entirely in the core Carbon Black segment (~80% of group revenue): its PBIT fell to ₹190.67 Cr from ₹315.83 Cr in Q1 FY27 (-39.6% QoQ) while segment revenue held near-flat (₹1,978.53 Cr vs ₹2,003.93 Cr), pulling the company's own-disclosed consolidated operating margin down to 10.81% from 14.76% in Q1. Finance costs also rose to ₹103.88 Cr from ₹92.51 Cr QoQ. This matches what brokerages flagged ahead of the print: ICICI Securities had called for muted Q2 FY27 profitability as the temporary inventory gains that flattered Q1 margins reversed, alongside a risk of destocking from falling crude prices. On a YoY basis, however, both operating margin (10.66%→10.81%) and net margin (2.86%→3.05%) edged up rather than compressed, per the company's own ratio disclosures — the sequential dip is a normalization off an unusually strong Q1, not a YoY deterioration. Against Street, Prabhudas Lilladher had modeled Q2 FY27 EBITDA down 16% YoY to ~₹305 Cr; the actual consolidated EBITDA works out to ~₹310 Cr (PAT + tax + finance costs + depreciation), with PAT up 20% YoY rather than down — a mild beat versus that cautious call. Management's FY27 guidance of a 14-15% improvement in EBITDA/tonne over the FY26 average (₹16,500-17,000/tonne) was reiterated as of the late-July concall and an analyst meet held September 29, 2026; this filing contains no tonnage disclosure to verify the per-tonne metric directly, but H1 FY27 consolidated EBITDA of ~₹710 Cr is up ~17.8% YoY from ~₹603 Cr in H1 FY26 — running ahead of the low end of that target, consistent with management's prior framing that volume growth is weighted to H2. No management press release or concall transcript was available in the records alongside this filing, so their own characterization of the quarter could not be cross-checked here. During the quarter the company paid the ₹4.50/share (₹177.06 Cr) interim dividend declared in July, and incorporated a new subsidiary, Nanovace Advanced Materials, on September 16, 2026 — a minor step in the group's chemicals diversification that is not yet financially material. The Chief–International Markets role also saw a resignation in early October, a governance item with no direct read-through to this quarter's numbers.

2 Nov 2026, 01:22 pm

Corporate Events

Board MeetingPCBL
2026
2Nov

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingPCBL
2026
22Sep

Board Meeting

The Sixty-fifth Annual General Meeting (AGM) of the Members …

BSE Filing ↗
DividendPCBL
2026
4Aug

₹4.5 / share

BSE Filing ↗
Board MeetingPCBL
2026
29Jul

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingPCBL
2025
29Apr

Board Meeting

Consider, approve and take on record the Audited Financial R…

BSE Filing ↗
Board MeetingPCBL
2024
29Oct

Board Meeting

Consider, approve and take on record the Unaudited Financial…

BSE Filing ↗
Board MeetingPCBL
2024
27Mar

Board Meeting

Consider and approve proposal for raising funds

BSE Filing ↗
DividendPCBL
2024
29Jan

₹5.5 / share

BSE Filing ↗
Board MeetingPCBL
2024
15Jan

Board Meeting

Consider and approve Unaudited Financial Results for the qua…

BSE Filing ↗
Board MeetingPCBL
2023
16Dec

Board Meeting

Consider and approve proposals for raising funds

BSE Filing ↗
Board MeetingPCBL
2023
17Oct

Board Meeting

consider, approve and take on record the Unaudited Financial…

BSE Filing ↗